These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9179773)

  • 1. In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen.
    Ryu CJ; Gripon P; Park HR; Park SS; Kim YK; Guguen-Guillouzo C; Yoo OJ; Hong HJ
    J Med Virol; 1997 Jun; 52(2):226-33. PubMed ID: 9179773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.
    Maeng CY; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ
    Virology; 2000 Apr; 270(1):9-16. PubMed ID: 10772975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees.
    Hong HJ; Ryu CJ; Hur H; Kim S; Oh HK; Oh MS; Park SY
    Virology; 2004 Jan; 318(1):134-41. PubMed ID: 14972542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg).
    Golsaz-Shirazi F; Amiri MM; Farid S; Bahadori M; Bohne F; Altstetter S; Wolff L; Kazemi T; Khoshnoodi J; Hojjat-Farsangi M; Chudy M; Jeddi-Tehrani M; Protzer U; Shokri F
    Antiviral Res; 2017 Aug; 144():153-163. PubMed ID: 28641998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both middle and large envelope proteins can mediate neutralization of hepatitis B virus infectivity by anti-preS2 antibodies: escape by naturally occurring preS2 deletions.
    Zhang J; Wang Q; Yuan W; Li J; Yuan Q; Zhang J; Xia N; Wang Y; Li J; Tong S
    J Virol; 2024 Aug; 98(8):e0192923. PubMed ID: 39078152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee.
    Iwarson S; Tabor E; Thomas HC; Goodall A; Waters J; Snoy P; Shih JW; Gerety RJ
    J Med Virol; 1985 May; 16(1):89-96. PubMed ID: 2413167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and Characterization of a Neutralizing Human Monoclonal Antibody to Hepatitis B Virus PreS1 from a Phage-Displayed Human Synthetic Fab Library.
    Jo G; Jeong MS; Wi J; Kim DH; Kim S; Kim D; Yoon JY; Chae H; Kim KH; Hong HJ
    J Microbiol Biotechnol; 2018 Aug; 28(8):1376-1383. PubMed ID: 30301315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrimination of hepatitis B virus (HBV) subtypes using monoclonal antibodies to the PreS1 and PreS2 domains of the viral envelope.
    Mimms LT; Floreani M; Tyner J; Whitters E; Rosenlof R; Wray L; Goetze A; Sarin V; Eble K
    Virology; 1990 Jun; 176(2):604-19. PubMed ID: 1693248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal antibody specific to the non-epitope region of hepatitis B virus preS1 contributes to more effective HBV detection.
    Zhang Z; Li X; Yi W; Li S; Hu C; Chen A
    Clin Biochem; 2013 Aug; 46(12):1105-1110. PubMed ID: 23608352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human monoclonal antibody against small envelope protein of hepatitis B virus with potent neutralization effect.
    Wang W; Sun L; Li T; Ma Y; Li J; Liu Y; Li M; Wang L; Li C; Xie Y; Wen Y; Liang M; Chen L; Tong S
    MAbs; 2016; 8(3):468-77. PubMed ID: 26713590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and Characterization of an Anti-Hepatitis B Virus preS1 Humanized Antibody that Binds to the Essential Receptor Binding Site.
    Wi J; Jeong MS; Hong HJ
    J Microbiol Biotechnol; 2017 Jul; 27(7):1336-1344. PubMed ID: 28478661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
    Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
    J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
    Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
    Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory activity of monoclonal antibody F35.25 on the interaction between hepatocytes (HepG2 cells) and preS1-specific ligands.
    Petit MA; Strick N; Dubanchet S; Capel F; Neurath AR
    Mol Immunol; 1991; 28(4-5):517-21. PubMed ID: 1712075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo hepatitis B virus-neutralizing activity of an anti-HBsAg humanized antibody in chimpanzees.
    Kim SH; Kim SH; Oh HK; Ryu CJ; Park SY; Hong HJ
    Exp Mol Med; 2008 Feb; 40(1):145-9. PubMed ID: 18305407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of a humanized antibody with specificity for preS2 surface antigen of hepatitis B virus.
    Park SS; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ
    Hybridoma; 1996 Dec; 15(6):435-41. PubMed ID: 8985755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
    Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
    World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anti-preS2 antibody protects human hepatocytes from hepatitis B virus infection.
    Guo M; Kang B; Zheng Q; Qian Q; Su C; Wu M; Yang J
    Acta Gastroenterol Belg; 2009; 72(3):306-11. PubMed ID: 19902863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A humanized antibody with specificity for hepatitis B surface antigen.
    Ryu CJ; Padlan EA; Jin BR; Yoo OJ; Hong HJ
    Hum Antibodies Hybridomas; 1996; 7(3):113-22. PubMed ID: 9057059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine.
    Tajiri K; Ozawa T; Jin A; Tokimitsu Y; Minemura M; Kishi H; Sugiyama T; Muraguchi A
    Antiviral Res; 2010 Jul; 87(1):40-9. PubMed ID: 20412816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.